









市場行情
/
股票
/
nasdaq-elan
/

Elanco Animal Health Inc

ELAN

22.305USD

+0.215+0.97%

收盤 12/19, 16:00（美東）報價延遲15分鐘

11.08B總市值

308.38本益比TTM



Elanco Animal Health Inc

22.305

+0.215+0.97%

概覽公司財務分析

概覽

公司

財務

分析

關於 Elanco Animal Health Inc 公司

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Elanco Animal Health Inc簡介



公司代碼ELAN

公司名稱Elanco Animal Health Inc

上市日期Sep 20, 2018

CEOSimmons (Jeffrey N)

員工數量9000

證券類型Ordinary Share

年結日Sep 20

公司地址450 Elanco Circle

城市INDIANAPOLIS

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編46221

電話18773526261

網址https://www.elanco.com/

公司代碼ELAN

上市日期Sep 20, 2018

CEOSimmons (Jeffrey N)

Elanco Animal Health Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

160.34K

+6.87%

Mr. Michael J. Harrington

Independent Director

109.58K

+10.39%

Mr. Art A. Garcia, CPA

Independent Director

91.28K

+12.74%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

89.71K

+12.99%

Mr. Paul S. Herendeen

Independent Director

84.81K

+13.84%

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

Mr. James Meer

Senior Vice President, Chief Accounting Officer

62.55K

-1.82%

Ms. Shiv O'Neill

Executive Vice President, General Counsel, Corporate Secretary

53.92K

+100.82%

名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

160.34K

+6.87%

Mr. Michael J. Harrington

Independent Director

109.58K

+10.39%

Mr. Art A. Garcia, CPA

Independent Director

91.28K

+12.74%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

89.71K

+12.99%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Pet Health

643.00M

51.81%

Farm Animal

583.00M

46.98%

Contract Manufacturing

15.00M

1.21%

地區USD

名稱

營收

佔比

International

648.00M

52.22%

United States

593.00M

47.78%

業務

地區

業務USD

名稱

營收

佔比

Pet Health

643.00M

51.81%

Farm Animal

583.00M

46.98%

Contract Manufacturing

15.00M

1.21%

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

Dodge & Cox

16.66%

Fidelity Management & Research Company LLC

10.21%

PRIMECAP Management Company

10.05%

The Vanguard Group, Inc.

9.75%

BlackRock Institutional Trust Company, N.A.

8.13%

其他

45.19%

持股股東

佔比

Dodge & Cox

16.66%

Fidelity Management & Research Company LLC

10.21%

PRIMECAP Management Company

10.05%

The Vanguard Group, Inc.

9.75%

BlackRock Institutional Trust Company, N.A.

8.13%

其他

45.19%

股東類型

持股股東

佔比

Investment Advisor

70.39%

Investment Advisor/Hedge Fund

36.66%

Hedge Fund

5.79%

Research Firm

1.90%

Individual Investor

1.13%

Pension Fund

1.08%

Bank and Trust

0.65%

Sovereign Wealth Fund

0.18%

Family Office

0.11%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

852

577.24M

120.43%

+30.91K

2025Q3

891

577.57M

121.95%

+32.95M

2025Q2

878

543.55M

113.98%

+36.20M

2025Q1

945

503.90M

116.31%

-73.53M

2024Q4

964

498.16M

117.36%

+7.74M

2024Q3

970

490.73M

118.81%

+19.54K

2024Q2

1004

491.01M

118.24%

+1.27M

2024Q1

1021

489.85M

119.72%

-100.34M

2023Q4

1018

489.74M

120.73%

-3.72M

2023Q3

1027

490.57M

119.00%

+3.49M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Dodge & Cox

82.90M

16.69%

-25.35K

-0.03%

Jun 30, 2025

Fidelity Management & Research Company LLC

48.24M

9.71%

+9.93M

+25.93%

Jun 30, 2025

PRIMECAP Management Company

51.77M

10.42%

+1.54M

+3.07%

Jun 30, 2025

The Vanguard Group, Inc.

47.65M

9.59%

-496.16K

-1.03%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

19.58M

3.94%

-484.75K

-2.42%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

19.55M

3.94%

+3.57M

+22.35%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

22.75M

4.58%

+2.28M

+11.15%

Jun 30, 2025

UBS Financial Services, Inc.

10.31M

2.08%

+5.99M

+138.56%

Jun 30, 2025

State Street Investment Management (US)

9.13M

1.84%

-125.36K

-1.35%

Jun 30, 2025

Fidelity Institutional Asset Management

16.64M

3.35%

+1.09M

+7.01%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

iShares U.S. Pharmaceuticals ETF

4.06%

Adaptiv Select ETF

3.38%

State Street SPDR S&P Pharmaceuticals ETF

3.15%

Brandes US Small-Mid Cap Value ETF

3.14%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

2.84%

VanEck Agribusiness ETF

2.3%

First Trust Health Care Alphadex Fund

1.92%

Federated Hermes MDT Large Cap Value ETF

1.9%

First Trust NASDAQ Pharmaceuticals ETF

1.33%

Invesco S&P MidCap 400 Pure Value ETF

1.22%

iShares U.S. Pharmaceuticals ETF

佔比4.06%

Adaptiv Select ETF

佔比3.38%

State Street SPDR S&P Pharmaceuticals ETF

佔比3.15%

Brandes US Small-Mid Cap Value ETF

佔比3.14%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

佔比2.84%

VanEck Agribusiness ETF

佔比2.3%

First Trust Health Care Alphadex Fund

佔比1.92%

Federated Hermes MDT Large Cap Value ETF

佔比1.9%

First Trust NASDAQ Pharmaceuticals ETF

佔比1.33%

Invesco S&P MidCap 400 Pure Value ETF

佔比1.22%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Elanco Animal Health Inc的前五大股東是誰？



Elanco Animal Health Inc的前五大股東如下：
Dodge & Cox
持有股份：82.90M
佔總股份比例：16.69%。
Fidelity Management & Research Company LLC
持有股份：48.24M
佔總股份比例：9.71%。
PRIMECAP Management Company
持有股份：51.77M
佔總股份比例：10.42%。
The Vanguard Group, Inc.
持有股份：47.65M
佔總股份比例：9.59%。
BlackRock Institutional Trust Company, N.A.
持有股份：19.58M
佔總股份比例：3.94%。